Journals / Türk Oftalmoloji Dergisi / 2010 / Cilt: 40 - Sayı: 1

Evaluation of optic nerve functions in patients treated with isotretinoin

İzotretinoin tedavisi alan hastalarda optik sinir fonksiyonlarının değerlendirilmesi

Pages
1–3
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although mean deviation (MD) and pattern standard deviation (PSD) values did not show any difference in the first and last visual field tests, in pattern deviation probability maps, the probability points

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Systemic administration of isotretinoin, one of the synthetic retinoids having effect on cell growth and differentiation, might have side effects on different systems.
📊
Key Findings & Data:All patients underwent a complete ophthalmologic examination and an automated threshold perimetry with Humphrey 30.2 test for visual field assessment.
💡
Conclusion & Impact:Although mean deviation (MD) and pattern standard deviation (PSD) values did not show any difference in the first and last visual field tests, in pattern deviation probability maps, the probability points
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Systemic administration of isotretinoin, one of the synthetic retinoids having effect on cell growth and differentiation, might have side effects on different systems. In this study, we aimed to evaluate optic nerve functions in patients treated with oral isotretinoin both clinically and with visual field tests. Material and Method: Fourteen patients planned to be treated with oral isotretinoin for nodulocystic acne were enrolled in this study. All patients underwent a complete ophthalmologic examination and an automated threshold perimetry with Humphrey 30.2 test for visual field assessment. Patients with normal findings at initial examination were prescribed 0.5-1 mg/kg oral isotretinoin and all examinations were repeated before cessation of the treatment. Results: Nine female and 5 male patients had a mean age of 22.07±3.5 years. The dose of oral isotretinoin was 1 mg/kg/day for 3 patients and 0.5 mg/kg/day for 11 patients, which was continued for 5.5±1.34 months. All patients had a best corrected visual acuity of 10/10, and direct and indirect light reflexes, color vision tests with Ishihara plates, anterior and posterior segment findings were normal at both the initial and follow-up examinations. Although mean deviation (MD) and pattern standard deviation (PSD) values did not show any difference in the first and last visual field tests, in pattern deviation probability maps, the probability points

Özet

Amaç: Hücrelerin büyüme ve farklılaşmasında etkili olan sentetik retinoidlerden biri olan izotretinoinin sistemik kullanımı farklı sistemlerde yan etkilere neden olabilmektedir. Bu çalışmada oral izotretinoin tedavisi alan hastaların optik sinir fonksiyonlarının klinik muayene ve görme alanı ile incelenmesi amaçlanmıştır. Gereç ve Yöntem: Nodülokistik akne nedeniyle oral izotretinoin tedavisi başlanan 14 hasta çalışmaya alındı. Tüm hastalara tam bir göz muayenesi ve Humphrey 30,2 eşik testi ile görme alanı değerlendirmesi yapıldı. İlk değerlendirme bulguları normal olan hastalara 0,5-1 mg/kg/gün oral izotretinoin tedavisi başlandı ve tedavinin sonlandırılması planlandığında tüm değerlendirmeler tekrar edildi. Sonuçlar: Ortalama 22,07±3,5 yaşında olan hastaların 9’u kadın, 5’i erkekti. Hastaların 3’üne 1mg/kg/gün, 11’ine 0,5 mg/kg/gün dozunda başlanan oral izotretinoin ortalama 5,5±1,34 ay süre ile kullanıldı. Başlangıç ve tedavi sonunda yapılan muayenede tüm hastaların en iyi düzeltilmiş görme keskinlikleri tam, direkt ve indirekt ışık refleksleri doğal, Ishiara kartları ile değerlendirilen renkli görmeleri normal, ön ve arka muayeneleri doğaldı. Görme alanı değerlendirmelerinde ortalama sapma (MD) ve patern standard sapma (PSD) değerlerinde tedavi öncesi ve sonrasında değişiklik görülmedi ancak patern deviasyon olasılık haritasındaki

🔖

Cite This Article

DİNÇ, E., ADIGÜZEL, U., KAYA, T. İ., YILDIRIM, Ö., SARI, A. (2022). Evaluation of optic nerve functions in patients treated with isotretinoin. Türk Oftalmoloji Dergisi, Cilt: 40 - Sayı: 1, 1–3. https://ajindex.com/articles/638454

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001;45:S150-7
  2. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications. Drugs. 2007;67:75-93
  3. McCaffery P, Drager UC. Regulation of retinol acid signaling in the embryonic nervous system: a master differantiation factor. Cytokine Growth Factor Rev. 2000;11:233-49
  4. Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001;132:299-305
  5. Cumurcu T, Sezer E, Kilic R, Bulut Y. Comparison of dose-related ocular side effects during systemic isotretinoin administration. Eur J Ophtalmol. 2009;19:196-200
  6. Karalezli A, Borazan M, Altinors DD; Dursun R, Kıyıcı H, Akova YA. Conjunctival impression cytology, ocular surface and tear-film changes in patients treated with systemic isotretinoin. Cornea. 2009;28:46-50
  7. Weleber RG, Denman ST, Hanifin JM, Cunningham WJ. Abnormal retinal function associated with isotretinoin therapy for acne. Arch Ophthalmol. 1986;104:831-7
  8. Welsh BM, Smith AL, Elder JE, Varigos GA. Night blindness precipitated by isotretinoin in the setting of hypovitaminosis A. Australasian J Dermatol. 1999;40:208-10
  9. Mollan SP, Woodcock M, Siddiqi R, Huntbach J, Good P, Scott RAH. Does use of isotretinoin rule out a career in flying? Br J Ophthalmol. 2006;90:957-9
  10. Bigby M, Stern RS. Adverse reaction to isotretinoin. J Am Acad Dermatol. 1988;18:543-52
  11. Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology. 2004;111:1248-50
  12. Nikiforidis G, Tsambaos D, Karamitsos D, Koutsojannis C, Georgiou S. Effects of oral isotretinoin on human auditory brainstem response. Dermatology. 1994;189:62-4
  13. Aydogan K, Karlı N. Effects of oral isotretinoin therapy on peripheral nevre functions: a preliminary study. Clin Exp Dermatol. 2006;32:81-4
  14. Chroni E, Pasmatzi E, Monastırlı A, Georgiou S, Katsoulas G, Polychronopoulos P, Tsambaos D. Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy. J Dermatol Treatment. 2006;17:6-8
  15. Ateş H, Uğurlu Ş, Özcan A, Özdemir N. Glokom. In: Aydın P, editör. Görme Alanı El Kitabı. İstanbul: Aksu Basım Yayın; 2005:115-31
  16. Aydoğan K, Turan OF, Onart S, Yazıcı B, Karadoğan SK, Tokgöz N. Neurological and neurophysiological effects of oral isotretinoin: a prospective investigation using auditory and visual evok